Latka logo
bit.bio logo

bit.biorevenue

Cambridge, England, United KingdomFounded 2019

bit.bio is an award-winning human synthetic biology company focused on coding cells for novel cures. They have developed an end-to-end platform for producing human cells for research, drug discovery, and cell therapy.

bit.bioLinkedInUpdated Oct 13, 2026
Annual revenue
$13.9M
Dec 2025EST
Employees
100
Dec 2025

bit.bio revenue

bit.bio has not published its revenue. GetLatka estimates it at about $13.9M a year (December 2025).

$0
$5M
$10M
$0
–
$13.9M
20192020–242025
ReportedEstimateFounded 2019 at $0; every reading has its own bar
As ofRevenueSource
Dec 2025$13.9MESTGetLatka estimate

bit.bio founders & employees

Mark Kotter founded bit.bio in 2019. bit.bio has 100 employees (December 2025, LinkedIn).

0
25
50
75
100
100
2025
ReportedOne figure per year; a reported figure wins over an estimate

bit.bio FAQ

What is bit.bio's revenue?

GetLatka estimates bit.bio's revenue at about $13.9M a year (December 2025). The company hasn't published its own figure.

How many employees does bit.bio have?

bit.bio has 100 employees as of December 2025, according to LinkedIn.

Who founded bit.bio?

Mark Kotter founded bit.bio in 2019.

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Oct 13, 2026Data disclaimerReport a correctionClaim this profileRun bit.bio? Join the podcast